Skip to main content
. 2016 May 19;101(3):608–615. doi: 10.1097/TP.0000000000001231

FIGURE 1.

FIGURE 1

AT1R-Ab concentration in patients with AMR, CMR, and no rejection. AT1R-Ab concentrations were significantly higher in patients with AMR (mean AT1R-Ab concentration 18.8 ± 10.6 U/ml) compared to those with no rejection (mean AT1R-Ab concentration 11.8 ± 7.4 U/ml). No significant difference was observed for patients with CMR (mean AT1R-Ab concentration 12.9 ± 6.7 U/ml) versus no rejection. AT1R-Ab concentrations for two remaining biopsies were reported as transplant glomerulopathy and were 9.4 and 10.9 U/ml, respectively.